- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2016
- Public Summary Document (PSD) March 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2016 PBAC Meeting - Word
Certolizumab pegol – March 2016
Certolizumab pegol: 200 mg/mL injection, 2 x 1 mL syringes, Cimzia®
Last updated
1 July 2016